Charles Schwab Investment Management Inc Procept Bio Robotics Corp Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 426,434 shares of PRCT stock, worth $29.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
426,434
Previous 402,565
5.93%
Holding current value
$29.7 Million
Previous $32.2 Million
6.47%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PRCT
# of Institutions
277Shares Held
39.5MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$337 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$242 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$107 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$86.5 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$82 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.1B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...